Oliver Langer Selected Research

Oliver Langer Research Topics

Disease

33	Breast Neoplasms (Breast Cancer) 01/2022 - 07/2010
13	Neoplasms (Cancer) 01/2020 - 08/2011
8	Alzheimer Disease (Alzheimer's Disease) 10/2021 - 09/2006
8	Epilepsy (Aura) 09/2018 - 09/2007
5	Temporal Lobe Epilepsy 04/2016 - 09/2007
3	Amyloidosis 06/2022 - 01/2020
3	Brain Neoplasms (Brain Tumor) 12/2019 - 12/2015
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2018 - 01/2017
3	Infections 04/2016 - 10/2004
2	Liver Diseases (Liver Disease) 05/2020 - 01/2016
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2020 - 04/2015
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 09/2018
2	Neoplasm Metastasis (Metastasis) 01/2017 - 01/2017
2	Status Epilepticus (Complex Partial Status Epilepticus) 10/2012 - 06/2011
2	Parkinson Disease (Parkinson's Disease) 10/2011 - 10/2004
2	Drug Resistant Epilepsy 06/2011 - 01/2010
2	Body Weight (Weight, Body) 12/2009 - 01/2008
1	Endotoxemia 03/2022
1	Inflammation (Inflammations) 03/2022
1	Lung Diseases (Lung Disease) 01/2022
1	Tardive Dyskinesia 01/2021
1	Inborn Genetic Diseases (Disease, Hereditary) 11/2020
1	Mental Disorders (Mental Disorder) 11/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2017
1	Hepatocellular Carcinoma (Hepatoma) 01/2017
1	Hypoxia (Hypoxemia) 11/2016
1	Glioma (Gliomas) 04/2016
1	Multiple Myeloma 04/2016
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2016
1	Parathyroid Neoplasms (Parathyroid Neoplasm) 04/2016
1	Prostatic Neoplasms (Prostate Cancer) 04/2016
1	Thyroid Neoplasms (Thyroid Cancer) 04/2016
1	Tuberculosis (Tuberculoses) 04/2016
1	Merkel Cell Carcinoma 04/2016
1	Cholestasis 01/2016
1	Drug-Related Side Effects and Adverse Reactions 09/2015
1	Stroke (Strokes) 04/2015

Drug/Important Bio-Agent (IBA)

37	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2022 - 09/2007
32	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2010
13	Pharmaceutical PreparationsIBA 03/2022 - 09/2006
11	tariquidar (XR9576)IBA 01/2020 - 12/2009
10	Adenosine Triphosphate (ATP)IBA 01/2022 - 10/2011
9	Verapamil (Calan)FDA LinkGeneric 01/2020 - 09/2007
8	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2022 - 10/2011
6	Erlotinib Hydrochloride (CP 358,774)FDA Link 08/2018 - 12/2015
5	multidrug resistance-associated protein 1IBA 06/2022 - 10/2013
5	Ciprofloxacin (Cipro)FDA LinkGeneric 08/2021 - 10/2004
5	ErbB Receptors (EGF Receptor)IBA 08/2018 - 04/2016
5	Anticonvulsants (Antiepileptic Drugs)IBA 10/2014 - 09/2007
4	Multidrug Resistance-Associated ProteinsIBA 08/2021 - 10/2011
4	Tyrosine Kinase InhibitorsIBA 01/2019 - 01/2017
4	ElacridarIBA 01/2018 - 04/2011
3	Amyloid beta-PeptidesIBA 10/2021 - 07/2009
2	AntiemeticsIBA 06/2022 - 01/2021
2	Bile Acids and Salts (Bile Acids)IBA 03/2022 - 01/2016
2	Metoclopramide (Reglan)FDA LinkGeneric 01/2021 - 01/2020
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 01/2012
2	Amyloid (Amyloid Fibrils)IBA 01/2017 - 01/2012
2	AcidsIBA 04/2016 - 01/2016
2	Pilocarpine (Ocusert)FDA LinkGeneric 10/2012 - 06/2011
1	Thiethylperazine (Thiethylperazine Malate)FDA Link 06/2022
1	Organic Anion TransportersIBA 03/2022
1	Peptides (Polypeptides)IBA 03/2022
1	AnionsIBA 03/2022
1	Rifampin (Rifampicin)FDA LinkGeneric 03/2022
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2021
1	technetium Tc 99m mebrofenin FDA LinkGeneric 05/2020
1	Contrast MediaIBA 12/2019
1	CorticosteroneIBA 11/2019
1	Biomarkers (Surrogate Marker)IBA 11/2018
1	Amino Acids FDA Link 01/2017
1	Fluorine-18IBA 11/2016
1	azomycinIBA 11/2016
1	Nucleoside Transport Proteins (Nucleoside Transporter)IBA 11/2016
1	pimonidazoleIBA 11/2016
1	Phenobarbital (Luminal)FDA Link 05/2016
1	Yttrium-90IBA 04/2016
1	Choline (Choline Chloride)IBA 04/2016
1	AerosolsIBA 04/2016
1	Dihydroxyphenylalanine (Dopa)IBA 04/2016
1	radium Ra 223 dichlorideIBA 04/2016
1	5-(2-fluoroethyl) 2,4- diethyl- 3- (ethylsulfanylcarbonyl)- 6- phenylpyridine- 5- carboxylateIBA 04/2016
1	Liposomes (Liposome)IBA 04/2016
1	fluoromethylcholineIBA 04/2016
1	Methionine (L-Methionine)FDA Link 04/2016
1	fluorocholineIBA 04/2016
1	melanin-concentrating hormone receptorIBA 04/2016
1	N,N'- bis(2- hydroxy- 5- (ethylene- beta- carboxy)benzyl)ethylenediamine N,N'-diacetic acidIBA 04/2016
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 04/2016
1	lipoarabinomannan (LAM)IBA 04/2016
1	SolutionsIBA 04/2016
1	Dictyostelium severin protein (severin)IBA 04/2016
1	23-seleno-25-homotaurocholic acidIBA 04/2016
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2016
1	gallium 68 PSMA-11IBA 04/2016
1	Deoxyglucose (2 Deoxy D glucose)IBA 07/2015

Therapy/Procedure

2	PET protocol 01/2020 - 11/2012
2	Drug Therapy (Chemotherapy) 01/2019 - 09/2018
2	Therapeutics 11/2018 - 09/2018
1	Boron Neutron Capture Therapy 01/2017